KABI PHARMACIA AKTIEBOLAG
Patent Owner
Stats
- 10 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Mar 27, 2001 most recent publication
Details
- 10 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,394 Total Citation Count
- Mar 25, 1981 Earliest Filing
- 25 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
6207178 Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereofExpiredDec 03, 98Mar 27, 01[A01N]
6034059 Treatment of catabolic states using authentic IGF-1 and hypocaloric amount of nutrientsExpiredMar 17, 93Mar 07, 00[A61K]
5691350 Use of linomide for treatment of retrovirus infections specifically HIV infectionsExpiredJun 05, 95Nov 25, 97[A61K]
5618817 Use of diphenylbutyl-piperazinecarboxamides in the treatment of substance disordersExpiredApr 25, 95Apr 08, 97[A61K]
5411732 Preparation of fused proteins, antibodies and processes thereforeExpiredOct 01, 93May 02, 95[A61K, C12N]
5182081 Product to be used in occlusive epicutaneous testing for the purpose of demonstrating contact allergy to formaldehydeExpiredFeb 01, 90Jan 26, 93[G01N, A61B]
5114971 Prostaglandin derivatives for the treatment of glaucoma or ocular hypertensionExpiredOct 23, 90May 19, 92[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
